Recipharm Expands Lyophilization Capacity in Italy

News
Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-09-07-2016
Volume 11
Issue 9

Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.

CDMO Recipharm has announced plans to expand its lyophilization capacity in Masate, Italy, to meet growing customer demand. An investment of EUR3.7 million (approximately $4.18 million) has been set aside for this expansion. A new lyophilizer will be purchased, bringing the total number of machines from five to six.

The CDMO offers lyophilization services for both vials and ampoules. The Masate facility specializes in aseptic manufacturing of parenterals.

Recipharm also invested EUR32 million (approximately $36 million) in Wasserburg, Germany in an ongoing project to increase lyophilization capacity at that site.

Source: Recipharm

Articles in this issue
Putting Shelf-Life to the Test
Putting Shelf-Life to the Test
The Enzymatic Catalysis Route to Going Green
The Enzymatic Catalysis Route to Going Green
PT0816_Outsourcing_Figure-1-New-1472762784733.jpg
CMOs Step Up to Test New Bioprocessing Technology
SGS Opens New Facility in Wiesbaden, Germany
CSafe Acquires Kallibox
CordenPharma in France Reports Successful FDA Inspection
Automated Infrared Microscope Effectively Analyzes Micro Samples
Copley Scientific Launches Products for Tablet Dissolution Testing
Eppendorf Expands Single-Use Vessel Portfolio
PANalytical launches the Empyrean Nano edition
Fuji Health Changes Name to Fuji Chemical Industries USA, Inc.
Regis Technologies Reports Successful FDA Inspection
Evonik Birmingham Laboratories Receives Renewal of EU GMP Certification
Quality Issues Cited at Frontida BioPharm
Recipharm Expands Lyophilization Capacity in Italy
Recent Videos
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content
Pharmaceutical research and development in laboratory, with focus on medicine preparation, powder substances, and glass vials for drug formulation and testing | Image Credit: © felix_brönnimann - stock.adobe.com

Dosage Form Compounding in the Workplace Environment

Paul L. Pluta;Alan M. Mancini;Nishant B. Thakar;Varanya Chaiyaperm
July 8th 2025
Article

An ordered pharmaceutical compounding process for use in 503A pharmacies, 503B outsourcing facilities, pharmaceutical industry, and other applications.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

low angle view of marble dome of United States Capitol building in Washington DC with blue sky and visible architecture features | Image Credit: © Philip - stock.adobe.com

9 Implications of Trump’s Tax-Cut and Spending Bill for the Bio/Pharmaceutical Industry

Christopher Cole
July 7th 2025
Article

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting strategy across the bio/pharmaceutical industry.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

medicine and vision concept - woman closeup and eye diagram, future technologies | Image Credit: ©Julia - stock.adobe.com

Advanced Solutions for Sustained Delivery of Ocular Therapies

Cynthia A. Challener
July 4th 2025
Article

Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.

Old rusty shovel in the ground on the building | Image Credit: © photolink - stock.adobe.com

Piramal Pharma Holds Groundbreaking at Kentucky Facility, Part of $90 Million Investment Plan

Patrick Lavery
July 2nd 2025
Article

The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.